ArticleBreast cancer research : BCR2020

Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs.

Tejaswini P Reddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.